Modified High-Dose Melphalan and Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis

High-dose melphalan and autologous stem cell transplantation (HDM/SCT) have been used in patients with immunoglobulin light chain (AL) amyloidosis for over 2 decades now with durable responses, prolonged survival, and decreasing treatment-related mortality. Historically, patients with poorer baselin...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biol Blood Marrow Transplant
Autors principals: Nguyen, Vina P., Landau, Heather, Quillen, Karen, Brauneis, Dina, Shelton, Anthony C., Mendelson, Lisa, Rahman, Hafsa, Sloan, J. Mark, Sarosiek, Shayna, Sanchorawala, Vaishali
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7553205/
https://ncbi.nlm.nih.gov/pubmed/29933072
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2018.06.018
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars